People · Operator
Named in public records as an officer, director or promoter · active 2013–2017 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Peptilogics, Inc. | — | Biotechnology | Series B | $40.9M | $1.2B | 2017 |
| Genia Technologies, Inc. | — | Biotechnology | Series A | $10.4M | $377.4M | 2013 |
Stefan Roever at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Stefan Roever on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Roger Chen | 1 | 11 |
| Jason Camm | 1 | 5 |
| Stephan Dietrich | 1 | 4 |
| Dietrich Stephan | 1 | 4 |
| Catherine Mott | 1 | 4 |
| Pratima Rao | 1 | 1 |
| Hannes Holste | 1 | 1 |
| Sanjay Kakkar | 1 | 1 |
| Rodney Turner | 1 | 1 |
| Randall Davis | 1 | 1 |
| Jonathan Steckbeck | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.